scispace - formally typeset
T

Trefor Higgins

Researcher at University of Alberta

Publications -  69
Citations -  1407

Trefor Higgins is an academic researcher from University of Alberta. The author has contributed to research in topics: Hemoglobin variants & Hemoglobinopathy. The author has an hindex of 20, co-authored 68 publications receiving 1300 citations.

Papers
More filters
Journal ArticleDOI

Laboratory Investigation of Hemoglobinopathies and Thalassemias: Review and Update

TL;DR: The availability of HPLC has streamlined many of these requirements, allowing an efficient stepwise diagnostic strategy for these complex disorders, and several guidelines have been published that outline the required steps for hemoglobinopathy and thalassemia investigation.
Journal ArticleDOI

Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods.

TL;DR: Some current HbA(1c) methods show clinically significant interferences with samples containing HbE or HbD traits, and ion-exchange chromatograms must be carefully examined to identify possible interference from these Hb variants.
Journal ArticleDOI

Between-Method Variation in Human Chorionic Gonadotropin Test Results

TL;DR: Differences in assay specificity and in composition of the calibrators are the most likely sources of between-method variation among commercial human chorionic gonadotropin (hCG) assays.
Journal ArticleDOI

Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine

TL;DR: This review summarizes existing evidence supporting the impact of laboratory medicine in healthcare and indicates the gaps in understanding, identifies deficiencies in current utilization, suggests potential solutions, and offers a vision of a future in which laboratory medicine is used optimally to support patient care.
Journal ArticleDOI

Measurement of Hba(1C) in patients with chronic renal failure.

TL;DR: Although most methods can measure HbA(1c) accurately in patients with renal failure, healthcare providers must interpret these test results cautiously in these patients due to the propensity for shortened erythrocyte survival in renal failure.